abstract |
The present invention provides immune response modifiers (IRMs) that are attached (typically attached, and preferably covalently attached) to macromolecular carrier materials. The IRM compound in such an IRM-carrier complex retains biological activity. Such attachment of the IRM to the macromolecular carrier material provides the local biological activity of the IRM. |